As a premier USA-based manufacturer of research-grade bioregulatory compounds, PX1 Research supplies high-purity Bronchogen for in vitro and preclinical laboratory investigations. Our analytical standards guarantee lot-to-lot consistency, precise sequence validation, and comprehensive quality documentation for cellular and animal models of pulmonary research.
As a premier USA-based manufacturer of research-grade bioregulatory compounds, PX1 Research supplies high-purity Bronchogen for in vitro and preclinical laboratory investigations. Our analytical standards guarantee lot-to-lot consistency, precise sequence validation, and comprehensive quality documentation for cellular and animal models of pulmonary research.
A professional manufacturer of Bronchogen for research applications synthesizes this short bioregulatory peptide using solid-phase peptide synthesis (SPPS) under strict quality controls to ensure high sequence purity and lot-to-lot consistency. In preclinical models, Bronchogen is studied for its potential role in bronchial epithelial function, cellular chromatin remodeling, and pulmonary tissue homeostasis affecting gas exchange dynamics.
When sourcing research compounds for respiratory tissue models, principal investigators require high-purity reagents that eliminate confounding biological variables. As a domestic US manufacturer, PX1 Research produces research peptides utilizing advanced SPPS technologies in ISO 17025 accredited environments. Each synthesized lot undergoes comprehensive analytical verification, including reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS), ensuring that laboratory researchers receive verified reagents tailored for precise experimental protocols.
Bronchogen is a synthetic tetrapeptide (Ala-Asp-Glu-Leu) derived from short-chain peptide bioregulator research. Bioregulatory peptides typically function by interacting directly with nucleosomal DNA or cellular transcription machinery, influencing targeted gene expression without altering the underlying genetic code. In vitro studies suggest that short peptide sequences can penetrate cellular membranes and localize within nuclear compartments, where they interact with specific histone proteins and DNA promoter regions.
In pulmonary models, Bronchogen's cellular mechanism centers on modulating gene expression pathways responsible for maintaining bronchial cell morphology and structural integrity. Researchers studying pulmonary biology evaluate how this peptide interacts with lung fibroblast and epithelial lineages to alter mRNA transcription rates of structural proteins, antioxidants, and surfactant components. To explore broader peptide mechanisms in cellular regulation, investigators frequently consult the PX1 Research Library.
Gas exchange efficiency across the alveolar-capillary membrane relies on the structural integrity of the bronchial epithelium, adequate surfactant production, and low levels of inflammatory stress. Preclinical rodent models subjected to toxic or hypoxic pulmonary insults have been utilized to evaluate how short regulatory peptides impact cellular repair mechanisms. In these experimental contexts, administration of Bronchogen was associated with preserved microvascular density and attenuated mucosal hyperplasia within bronchial tissues.
In vitro data indicate that Bronchogen exposure in cultured human pulmonary fibroblasts and bronchial epithelial cells alters the expression of markers associated with cellular senescence and oxidative stress. By maintaining alveolar surface architecture and reducing aberrant extracellular matrix deposition in animal models, the peptide facilitates research into how localized cellular homeostasis supports diffusion kinetics and arterial gas tensions. Investigators evaluating peptide kinetics can review Bronchogen research specs to align experimental conditions with literature benchmarks.
Selecting a professional supplier requires reviewing rigorous quality documentation. Raw peptide synthesis can yield deletion sequences, incomplete coupling products, or residual organic solvents if purification protocols are inadequate. A valid Certificate of Analysis (COA) must provide quantitative proof of peptide purity and structural identity rather than self-certified claims.
At PX1 Research, every batch of Bronchogen undergoes rigorous analytical testing prior to release. RP-HPLC testing establishes precise chromatographic purity, ensuring a minimum baseline of 99% active target peptide. ESI-MS confirms the precise molecular mass (460.48 g/mol), verifying sequence integrity. Furthermore, because bacterial endotoxins (lipopolysaccharides) can confound inflammatory cytokine assays in cellular and animal models, PX1 Research performs quantitative Chromogenic LAL (Limulus Amebocyte Lysate) testing on every lot to guarantee ultra-low endotoxin thresholds suitable for sensitive biological assays.
To contextualize Bronchogen's specific biological targets, researchers often compare it against other short-chain synthetic bioregulators and cytoprotective peptides within preclinical research paradigms. While Bronchogen exhibits high specificity for bronchial epithelial cellular models, related synthetic peptides target distinct organ systems or systemic repair mechanisms.
For instance, Epitalon is a synthetic tetrapeptide evaluated primarily for telomerase induction and neuroendocrine regulation in aging models. Similarly, Vilon is studied for its immunomodulatory interactions with chromatin structure in thymocyte cultures, whereas BPC-157 represents a broader gastrointestinal and musculoskeletal cytoprotective compound evaluated in focal tissue repair models. Understanding these structural and functional distinctions allows research laboratories to design controlled comparative studies targeting specific tissue cascades.
Proper reconstitution is critical to maintain peptide stability and prevent physical aggregation during in vitro or ex vivo assays. Research-grade Bronchogen is supplied as a lyophilized (freeze-dried) sterile powder in sealed glass vials. Reconstitution should be performed under a laminar flow hood using aseptic techniques to prevent microbial contamination.
For most cell culture and biochemical protocols, sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% Sodium Chloride Injection, USP is utilized as the primary diluent. When preparing stock solutions for sensitive cell culture assays where benzyl alcohol might interfere with viability metrics, sterile phosphate-buffered saline (PBS, pH 7.4) or sterile nuclease-free water is recommended. Gentle swirling or slow inversion should be used to dissolve the cake; vigorous vortexing or mechanical agitation must be avoided to prevent surface-induced aggregation or denaturing of the peptide chain.
Lyophilized Bronchogen displays optimal long-term stability when stored at sub-zero temperatures. For extended storage (up to 24 months), lyophilized vials should be kept at -20°C or -80°C in a desiccated environment protected from light exposure. Short-term storage of dry powder during active experimental phases can be maintained at refrigerated temperatures (2°C to 8°C) for several weeks without significant degradation.
Once reconstituted into aqueous solution, the shelf life of the compound decreases. Reconstituted aliquots stored at 2°C to 8°C should be utilized within 7 to 14 days to minimize hydrolytic breakdown. For long-term liquid storage, reconstitate using sterile buffers, divide into single-use experimental aliquots to eliminate freeze-thaw cycles, and store at -80°C. Avoiding repeated freeze-thaw sequences is essential for preserving exact concentration gradients across multi-week laboratory trials.
Acquiring reliable research peptides requires a trusted domestic supply chain capable of scaling alongside experimental demands. Substandard overseas manufacturing often suffers from batch inconsistencies, lack of ISO verification, extended transport times under uncontrolled temperature conditions, and absent endotoxin reporting.
PX1 Research operates state-of-the-art US manufacturing and dispatch facilities located in California and Arizona, providing immediate same-day shipping (Monday through Friday) for order requests received before cut-off times. Academic institutions, biotechnology firms, and contract research organizations (CROs) seeking bulk supply agreements or custom synthesis parameters can access dedicated institutional pricing and dedicated support through our wholesale peptide program.
What is Bronchogen used for in laboratory research?
Bronchogen is synthesized strictly as a research-grade peptide compound for in vitro and preclinical laboratory investigation. Researchers utilize it to examine bronchial epithelial gene expression, cell proliferation cascades, oxidative stress responses, and tissue homeostasis in respiratory models.
How does PX1 Research verify the purity of Bronchogen?
Every lot of Bronchogen produced by PX1 Research undergoes independent third-party analytical testing, including RP-HPLC to verify chromatographic purity (typically ≥99%) and Mass Spectrometry (ESI-MS) to confirm exact molecular mass. Endotoxin levels are verified via Chromogenic LAL assays.
What is the sequence and molecular weight of Bronchogen?
Bronchogen is a synthetic tetrapeptide consisting of the amino acid sequence Ala-Asp-Glu-Leu (Alanine-Aspartate-Glutamate-Leucine) with a chemical formula of C18H31N4O9 and a molecular mass of approximately 460.48 g/mol.
How should lyophilized Bronchogen be stored upon delivery?
Upon receipt, lyophilized Bronchogen should be stored at -20°C or -80°C for long-term stability. Vials should be protected from light and moisture. Reconstituted liquid solutions should be kept refrigerated at 2°C to 8°C and used within 7–14 days, or aliquoted and stored at -80°C.
What diluents are recommended for reconstituting Bronchogen in vitro?
Depending on the downstream assay, researchers typically reconstitute Bronchogen using sterile Bacteriostatic Water, 0.9% Sodium Chloride, or sterile Phosphate-Buffered Saline (PBS, pH 7.4). Swirl gently to dissolve and avoid aggressive agitation.
Why is endotoxin testing critical for bioregulatory peptides?
Bacterial endotoxins can trigger innate inflammatory signaling in cell culture or tissue models, generating false positives or confounding data in respiratory gene expression studies. PX1 Research tests every lot to ensure low endotoxin levels prior to dispatch.
Does PX1 Research offer bulk or institutional sourcing for Bronchogen?
Yes. PX1 Research supports universities, CROs, and industrial laboratories with scalable manufacturing, dedicated batch reservation, and custom fulfillment options via our wholesale laboratory portal.
Is Bronchogen approved for human consumption or clinical therapy?
No. Bronchogen provided by PX1 Research is strictly sold as a chemical reagent for laboratory research use only. It is not intended for human or animal consumption, diagnostic procedures, or therapeutic administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.